Mesenchymal Stem Cells Derived from Dental Pulp: A Review

The mesenchymal stem cells of dental pulp (DPSCs) were isolated and characterized for the first time more than a decade ago as highly clonogenic cells that were able to generate densely calcified colonies. Now, DPSCs are considered to have potential as stem cell source for orthopedic and oral maxill...

Full description

Saved in:
Bibliographic Details
Main Authors: Edgar Ledesma-Martínez (Author), Víctor Manuel Mendoza-Núñez (Author), Edelmiro Santiago-Osorio (Author)
Format: Book
Published: Hindawi Limited, 2016-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_bbee2579a9864f588b1c2021b976f3f1
042 |a dc 
100 1 0 |a Edgar Ledesma-Martínez  |e author 
700 1 0 |a Víctor Manuel Mendoza-Núñez  |e author 
700 1 0 |a Edelmiro Santiago-Osorio  |e author 
245 0 0 |a Mesenchymal Stem Cells Derived from Dental Pulp: A Review 
260 |b Hindawi Limited,   |c 2016-01-01T00:00:00Z. 
500 |a 1687-966X 
500 |a 1687-9678 
500 |a 10.1155/2016/4709572 
520 |a The mesenchymal stem cells of dental pulp (DPSCs) were isolated and characterized for the first time more than a decade ago as highly clonogenic cells that were able to generate densely calcified colonies. Now, DPSCs are considered to have potential as stem cell source for orthopedic and oral maxillofacial reconstruction, and it has been suggested that they may have applications beyond the scope of the stomatognathic system. To date, most studies have shown that, regardless of their origin in third molars, incisors, or exfoliated deciduous teeth, DPSCs can generate mineralized tissue, an extracellular matrix and structures type dentin, periodontal ligament, and dental pulp, as well as other structures. Different groups worldwide have designed and evaluated new efficient protocols for the isolation, expansion, and maintenance of clinically safe human DPSCs in sufficient numbers for various therapeutics protocols and have discussed the most appropriate route of administration, the possible contraindications to their clinical use, and the parameters to be considered for monitoring their clinical efficacy and proper biological source. At present, DPSC-based therapy is promising but because most of the available evidence was obtained using nonhuman xenotransplants, it is not a mature technology. 
546 |a EN 
690 |a Internal medicine 
690 |a RC31-1245 
655 7 |a article  |2 local 
786 0 |n Stem Cells International, Vol 2016 (2016) 
787 0 |n http://dx.doi.org/10.1155/2016/4709572 
787 0 |n https://doaj.org/toc/1687-966X 
787 0 |n https://doaj.org/toc/1687-9678 
856 4 1 |u https://doaj.org/article/bbee2579a9864f588b1c2021b976f3f1  |z Connect to this object online.